Sanara MedTech Inc. (SMTI) Tops Q3 EPS by 28c

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q3 EPS of ($0.34), $0.28 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $20.7 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Macquarie Upgrades DiDi Global (DIDIY) to Outperform
• Syensqo SA (SYENS:BB) PT Raised to EUR100 at JPMorgan